China is now the dominant exposure in some well-followed global emerging markets equity benchmarks– so what does that mean for the majority of portfolios that have direct or indirect exposure to the country?

In this presentation, Phil Wool will talk about ways to assess : 

·  China vs. a more diversified EM exposure, which one makes more sense?

·  What is the investment thesis for China for a global investor?

·  Does a “Western” centric approach to investing work in China? 

Speaker Bio:

Managing Director, Head of Investment Solutions, Rayliant Global Advisors

Phillip conducts research in support of Rayliant’s products, with a focus on quantitative approaches to asset allocation and return predictability within asset classes, as well as the design of equity strategies tailored to emerging markets, including Chinese A shares.

Prior to joining Rayliant, Phillip was an assistant professor of Finance at the State University of New York in Buffalo, where he pursued research on quantitative trading strategies and investor behavior, and taught investment management. Before that, he worked as a research analyst covering alternative investments for Hammond Associates, an institutional fund consultant.

Phillip received a BA in economics and a BSBA in finance and accounting from Washington University in St. Louis, and earned his Ph.D. in finance from UCLA, where his research focused on the portfolio holdings and trading activity of mutual fund managers and activist investors.

$0 CFANC Members

$10 Non-Members/Guests